MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 140 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,051,868 | -22.1% | 1,704,902 | -3.2% | 0.00% | -33.3% |
| Q2 2023 | $21,900,242 | -7.9% | 1,761,885 | +3.8% | 0.00% | 0.0% |
| Q1 2023 | $23,789,457 | +98824.9% | 1,698,033 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $24,048 | -99.9% | 1,680,522 | +0.7% | 0.00% | -50.0% |
| Q3 2022 | $42,586,000 | -8.0% | 1,668,086 | +2.4% | 0.01% | -14.3% |
| Q2 2022 | $46,296,000 | -11.3% | 1,629,600 | +10.1% | 0.01% | 0.0% |
| Q1 2022 | $52,220,000 | -12.6% | 1,480,580 | +3.8% | 0.01% | 0.0% |
| Q4 2021 | $59,761,000 | -8.8% | 1,426,294 | +6.8% | 0.01% | -22.2% |
| Q3 2021 | $65,540,000 | +40.1% | 1,335,377 | +19.1% | 0.01% | +50.0% |
| Q2 2021 | $46,785,000 | +64.7% | 1,121,156 | +40.6% | 0.01% | +50.0% |
| Q1 2021 | $28,412,000 | +1472.3% | 797,208 | +1137.2% | 0.00% | – |
| Q4 2020 | $1,807,000 | – | 64,438 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |